TRAVERE THERAPEUTICS INC's ticker is TVTX and the CUSIP is 89422G107. A total of 173 filers reported holding TRAVERE THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 1.37 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $9,412,515 | +6.9% | 418,520 | 0.0% | 0.36% | +7.8% |
| Q4 2022 | $8,801,476 | +44.2% | 418,520 | +69.0% | 0.33% | +32.8% |
| Q3 2022 | $6,103,000 | +1.7% | 247,678 | 0.0% | 0.25% | +5.9% |
| Q2 2022 | $6,001,000 | -6.0% | 247,678 | 0.0% | 0.24% | +5.4% |
| Q1 2022 | $6,383,000 | -3.4% | 247,678 | +16.4% | 0.22% | +5.2% |
| Q4 2021 | $6,607,000 | +28.0% | 212,869 | 0.0% | 0.21% | +28.3% |
| Q3 2021 | $5,162,000 | +66.2% | 212,869 | 0.0% | 0.17% | +64.4% |
| Q2 2021 | $3,106,000 | -41.6% | 212,869 | 0.0% | 0.10% | -44.8% |
| Q1 2021 | $5,315,000 | – | 212,869 | – | 0.18% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 1,084,300 | $15,820,000 | 3.32% |
| ARMISTICE CAPITAL, LLC | 5,748,000 | $83,863,000 | 1.50% |
| RA Capital Management | 5,614,428 | $81,915,000 | 1.32% |
| Krensavage Asset Management, LLC | 140,000 | $2,043,000 | 0.69% |
| CM Management, LLC | 60,000 | $875,000 | 0.63% |
| Altium Capital Management LP | 170,484 | $2,487,000 | 0.58% |
| HighVista Strategies LLC | 53,498 | $781,000 | 0.55% |
| Sio Capital Management, LLC | 150,000 | $2,189,000 | 0.54% |
| MANGROVE PARTNERS IM, LLC | 295,037 | $4,305,000 | 0.44% |
| Rock Springs Capital Management LP | 1,494,164 | $21,800,000 | 0.43% |